Granulocyte colony–stimulating factor priming improves haploidentical stem cell transplantation in high-risk acute myeloid leukemia subsets: a new role for an old work horse.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Biology of Blood and Marrow Transplantation

• Publication date

  2014-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.BBMT.2014.10.013PMID 25464120
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Unmanipulated haploidentical transplants compared with other alternative donors and matched sibling grafts.

  2014cited by this paper
• Niche displacement of human leukemic stem cells uniquely allows their competitive replacement with healthy HSPCs

  2014cited by this paper
• Current and emerging strategies for the prevention of graft-versus-host disease

  2014cited by this paper
• T-cell-replete haploidentical HSCT with low-dose anti-T-lymphocyte globulin compared with matched sibling HSCT and unrelated HSCT.

  2014cited by this paper
• "Designed" grafts for HLA-haploidentical stem cell transplantation.

  2014cited by this paper
• T-cell replete haploidentical donor transplantation using post-transplant CY: an emerging standard-of-care option for patients who lack an HLA-identical sibling donor

  2014cited by this paper
• Transplantation tolerance: from theory to clinic

  2014cited by this paper
• Effects of priming with recombinant human granulocyte colony-stimulating factor on conditioning regimen for high-risk acute myeloid leukemia patients undergoing human leukocyte antigen-haploidentical hematopoietic stem cell transplantation: a multicenter randomized controlled study in southwest Chin

  2014cited by this paper
• G-CSF: From granulopoietic stimulant to bone marrow stem cell mobilizing agent.

  2014cited by this paper
• Modification of T Cell Responses by Stem Cell Mobilization Requires Direct Signaling of the T Cell by G-CSF and IL-10

  2014cited by this paper
• Advances in haplo-identical stem cell transplantation in adults with high-risk hematological malignancies.

  2014cited by this paper
• G-CSF regulates hematopoietic stem cell activity, in part, through activation of toll-like receptor signaling

  2014cited by this paper
• Calcineurin inhibitor--free graft-versus-host disease prophylaxis with post-transplantation cyclophosphamide and brief-course sirolimus following reduced-intensity peripheral blood stem cell transplantation.

  2014cited by this paper
• Aldehyde Dehydrogenase Expression Drives Human Regulatory T Cell Resistance to Posttransplantation Cyclophosphamide

  2013cited by this paper
• Haploidentical, unmanipulated, G-CSF-primed bone marrow transplantation for patients with high-risk hematologic malignancies.

  2013cited by this paper
• Favorable effect of priming with granulocyte colony-stimulating factor in remission induction of acute myeloid leukemia restricted to dose escalation of cytarabine.

  2012cited by this paper
• Human leukocyte antigen-haploidentical stem cell transplantation using T-cell-replete bone marrow grafts

  2012cited by this paper
• Haploidentical hematopoietic transplantation: current status and future perspectives.

  2011cited by this paper
• Bone marrow CD169+ macrophages promote the retention of hematopoietic stem and progenitor cells in the mesenchymal stem cell niche

  2011cited by this paper
• Innovative Platforms for Haploidentical Stem Cell Transplantation: The Role of Unmanipulated Donor Graft

  2011cited by this paper
• Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia.

  2003cited by this paper
• Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells.

  2000cited by this paper
• Clinical Trials and Observations

  year unknowncited by this paper

• Update on Non-M3 Acute Myeloid Leukemia — Etiology, Classification, Risk Stratification, Emergencies, Complications, Disease in Special Circumstances and Current and Future Therapeutics

  2015cites this paper